Skip to main content

New five-year AWMSG Strategy launched

12 April 2024

AWTTC is very happy to announce that the latest five-year All Wales Medicines Strategy Group (AWMSG) Strategy, setting out its ambitions and goals for 2024 to 2029, has been launched and is now available for you to read.

AWTTC has worked very closely with AWMSG to develop this Strategy over the past year, which is now available following extensive discussions with AWMSG members and engagement with a wide range of partner organisations to ensure that it meets the needs of the people of Wales and aligns to the priorities of both NHS Wales and Welsh Government.

AWMSG will collaborate with key partner organisations across NHS Wales so that together they can work towards meeting their four ambitions: improving outcomes for patients; ensuring the right medicines are available at the right time; minimising medicines-related harm and improving safety; and optimising the value the NHS achieves from its investments in medicines.

The strategy aims to make significant progress in a broad range of objectives that have been grouped under eight Goals:

  1. Advice, resources and guidance reflect the priorities and needs of people and health and social care professionals in Wales
  2. AWMSG advice, resources and guidance are disseminated, widely promoted and routinely implemented
  3. Data and technology are used to improve value, patient outcomes and safety
  4. Medicines assessment processes are rigorous, timely and deliver value
  5. Health and social care professionals receive high-quality training in the safe and effective use of medicines
  6. People in Wales take their medicines in a way that maximises their health outcomes
  7. Waste associated with medicines use is reduced and sustainability is improved
  8. The benefits of genetic-informed precision medicines are realised in Wales.

We encourage you to please read the full Strategy document for more information, and get touch with if you have any questions.

Follow AWTTC: